NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Back to search
Official data from USPTO
LINEAGE CELL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
03/12/2024
Trademark type
Combined
Nice classes
42
Filing date
02/14/2023
Registration date
03/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
03/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/23/2023
First use in commerce
01/23/2023
Drawing code
3
Owner type
03
Owner location
Carlsbad, CA
Examiner
JANSON, ANDREW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a dark blue horizontal line followed by three light blue horizontal lines followed by five light blue and orange horizontal lines, immediately followed by the stylized word "LINEAGE" in white stacked on top of the stylized words "CELL THERAPEUTICS" in white. The black in the drawing represents background area and is not part of the mark.
Holders and representatives
Holders
Lineage Cell Therapeutics, Inc.
Representatives
HAROLD MILSTEIN SHEPPARD MULLIN RICHTER & HAMPTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical and biological research and development services in the field of cellular therapiescell-based tissue regeneration and engineeringextracellular matrix biomaterialcellular repair technologycellular replacement therapycellular restoration therapycellular therapy delivery technology and cell culturing; Providing medical research information in the field of cellular therapiescell-based tissue regeneration and engineeringextracellular matrix biomaterialcellular repair technologycellular replacement therapycellular restoration therapycellular therapy delivery technology and cell culturing
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/17/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/17/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/17/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/17/2023
DOCK
ASSIGNED TO EXAMINER
11/13/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2023
NWAP
NEW APPLICATION ENTERED
02/17/2023
Continuous trademark protection
Get notified about every new filing that threatens LINEAGE CELL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.